HomeTopics › Gallstones and Biliary Disease

Gallstones and Biliary Disease

GMJ News knowledge hub · last reviewed August 2026 · Georgian Medical Journal

SummaryStatisticsGlossaryGMJ newsFAQDocumentsOrganizationsResearch

Gallstone disease — the formation of cholesterol or pigment stones within the gallbladder — affects approximately 10-15% of adults in Western populations, of whom around 80% remain asymptomatic for life, but the symptomatic minority generate one of the highest surgical workloads in general surgery worldwide, with laparoscopic cholecystectomy among the most frequently performed operations globally (WHO). The critical clinical distinctions are between biliary colic (transient cystic duct obstruction, self-limiting, no fever or inflammatory markers), acute cholecystitis (sustained obstruction with gallbladder wall inflammation — Tokyo Guidelines severity grading; early laparoscopic cholecystectomy within 72 hours is superior to delayed surgery), choledocholithiasis (common bile duct stone — requires ERCP) and acute cholangitis (Charcot’s triad — a biliary emergency requiring urgent biliary drainage and carrying substantial mortality if decompression is delayed).

Key messages

10-15% of Western adults have gallstones — 80% remain asymptomatic for life
Gallstone prevalence: approximately 10-15% of adults in Western populations; higher in Latin America and among Native American populations; lower in sub-Saharan Africa and East Asia. Approximately 80% remain asymptomatic indefinitely, and asymptomatic gallstones found incidentally on imaging do NOT require cholecystectomy (annual rate of developing symptoms: approximately 1-2%). Risk factors ("the 5 Fs" is an outdated and imprecise mnemonic): female sex, increasing age, obesity, rapid weight loss, pregnancy and multiparity, family history, diabetes, ceftriaxone, octreotide, ileal disease or resection (bile salt malabsorption), haemolysis (pigment stones).
Distinguish biliary colic from acute cholecystitis — the diagnostic fork
Biliary colic: transient cystic duct obstruction by a stone that then falls back. Severe, constant (not colicky despite the name) right upper quadrant or epigastric pain, often radiating to the right scapula, lasting 30 minutes to several hours, then resolving completely. NO fever, NO systemic upset, normal WCC and CRP. Acute cholecystitis: sustained obstruction → gallbladder wall inflammation. Pain persisting >6 hours, fever, positive Murphy's sign (inspiratory arrest on RUQ palpation), raised WCC and CRP, gallbladder wall thickening and pericholecystic fluid on ultrasound. This distinction determines whether the patient needs urgent admission and surgery or elective referral.
Early laparoscopic cholecystectomy beats delayed surgery in acute cholecystitis
For acute cholecystitis, early laparoscopic cholecystectomy (within 72 hours of symptom onset, and certainly within the index admission) is superior to initial conservative management with delayed interval surgery: shorter total hospital stay, no increase in conversion or complication rate, and avoidance of the substantial proportion of patients who represent with recurrent or complicated disease while awaiting interval surgery (ACDC trial, Ann Surg 2013; Cochrane). Tokyo Guidelines (TG18) grade severity: Grade I (mild — no organ dysfunction); Grade II (moderate — marked local inflammation, WCC >18, palpable mass, >72h duration); Grade III (severe — organ dysfunction). Grade III with prohibitive operative risk: percutaneous cholecystostomy as a temporising measure.
Acute cholangitis — Charcot's triad is a biliary emergency
Acute cholangitis: infection of an obstructed biliary tree. Charcot's triad — fever, jaundice, right upper quadrant pain (present in approximately 50-70%). Reynolds' pentad adds hypotension and confusion — indicating suppurative cholangitis with septic shock. Mortality without decompression is very high. Management: resuscitation; blood cultures; broad-spectrum IV antibiotics; and — the definitive intervention — URGENT BILIARY DRAINAGE, usually ERCP with sphincterotomy and stone extraction, within 24 hours (within 12 hours for Grade III/severe). Antibiotics alone do not treat an obstructed infected biliary system; delay in decompression is the principal driver of mortality.
Common bile duct stones — predict, then image, then ERCP
Choledocholithiasis (CBD stone) should be suspected with: jaundice; raised bilirubin and ALP (cholestatic pattern); dilated CBD (>6mm, or >8-10mm post-cholecystectomy) on ultrasound; history of pancreatitis or cholangitis. Investigation pathway: high probability → ERCP directly (therapeutic); intermediate probability → MRCP or endoscopic ultrasound (EUS) first (both highly sensitive, non-invasive, avoid unnecessary ERCP); low probability → proceed to cholecystectomy with or without intraoperative cholangiography. ERCP carries a 3-5% risk of post-ERCP pancreatitis — it should be therapeutic, not diagnostic.
Index cholecystectomy after gallstone pancreatitis — do not discharge without it
After an episode of gallstone pancreatitis, laparoscopic cholecystectomy should be performed during the SAME admission (index cholecystectomy) for mild disease, or within 2 weeks — because the risk of recurrent biliary events (recurrent pancreatitis, cholecystitis, cholangitis) while awaiting delayed surgery is substantial (approximately 15-30% within 6 weeks). The PONCHO trial (Lancet 2015) confirmed same-admission cholecystectomy significantly reduced recurrent gallstone-related complications versus interval surgery. For necrotising or severe pancreatitis, cholecystectomy is deferred until collections have resolved or stabilised.

Key statistics

10-15%
gallstone prevalence in Western adult populations
WGO/SAGES
~80%
of gallstones remain asymptomatic — incidental stones do NOT need surgery
WGO/NICE
<72 hours
target for early laparoscopic cholecystectomy in acute cholecystitis (superior to delayed)
ACDC/Tokyo TG18
Charcot triad
fever + jaundice + RUQ pain = acute cholangitis = urgent biliary drainage within 24h
Tokyo TG18
3-5%
risk of post-ERCP pancreatitis — ERCP should be therapeutic, not diagnostic
ESGE/ASGE
PONCHO 2015
same-admission cholecystectomy after gallstone pancreatitis reduces recurrent events (Lancet)
Lancet 2015

Gallstone disease — clinical presentations and required urgency

Source: Tokyo Guidelines TG18 / WGO. Cholangitis is the most time-critical; asymptomatic stones need no intervention.

Glossary of key terms

Tokyo Guidelines (TG18) severity grading
Surgery/Hepatobiliary
The international standard for grading acute cholecystitis and cholangitis severity. Acute cholecystitis: Grade I (mild) — no organ dysfunction, mild local inflammation; Grade II (moderate) — WCC >18×10⁹/L, palpable tender RUQ mass, duration >72 hours, marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, biliary peritonitis, emphysematous cholecystitis); Grade III (severe) — dysfunction in any of: cardiovascular (vasopressor requirement), neurological, respiratory (PaO2/FiO2 <300), renal (creatinine >176 μmol/L), hepatic (INR >1.5), haematological (platelets <100). Grading determines whether early cholecystectomy, drainage or intensive support is required first.
Murphy's sign
Clinical examination
The examiner places fingers below the right costal margin at the mid-clavicular line and asks the patient to inspire deeply. As the inflamed gallbladder descends onto the examining hand, the patient experiences sharp pain and abruptly stops inspiration — a positive Murphy's sign. Sensitivity approximately 65%, specificity approximately 87% for acute cholecystitis in adults; substantially less reliable in the elderly (who may present with minimal signs and normal inflammatory markers despite advanced gangrenous cholecystitis) and in patients on corticosteroids. Sonographic Murphy's sign (maximal tenderness elicited by the ultrasound probe directly over the visualised gallbladder) has higher accuracy than the clinical sign.
Critical view of safety (CVS)
Surgical safety
The standard technique to prevent bile duct injury — the most feared complication of laparoscopic cholecystectomy (incidence approximately 0.3-0.5%, with severe long-term morbidity). Three criteria must ALL be met before any structure is clipped or divided: (1) The hepatocystic triangle is cleared of fat and fibrous tissue; (2) The lower third of the gallbladder is separated from the cystic plate (liver bed); (3) Exactly TWO structures are seen entering the gallbladder — the cystic duct and cystic artery, and no others. If the CVS cannot be achieved (severe inflammation, fibrosis, Mirizzi syndrome), the correct action is to convert to open surgery, perform a subtotal (fenestrating or reconstituting) cholecystectomy, or abandon and drain — never to proceed on assumption.
Mirizzi syndrome
Hepatobiliary
Extrinsic compression of the common hepatic duct by a large stone impacted in Hartmann's pouch or the cystic duct, causing obstructive jaundice. Csendes classification: Type I — external compression only; Types II-IV — progressive cholecystocholedochal fistula formation with increasing erosion into the common duct wall. Clinical importance: it produces obstructive jaundice with gallstones but no CBD stone on imaging; it dramatically increases the risk of bile duct injury during cholecystectomy (the anatomy is distorted and inflammation is dense); it is associated with gallbladder carcinoma in approximately 5-28% of cases. Preoperative recognition (MRCP) allows appropriate operative planning — usually subtotal cholecystectomy, sometimes open, occasionally with bilioenteric reconstruction.
Gallbladder cancer and porcelain gallbladder
Oncology/Surgery
Gallbladder adenocarcinoma is uncommon but highly lethal (5-year survival <10% when not incidental) — with striking geographical variation (very high incidence in northern India, Chile, Bolivia, Poland; low in Western Europe and North America). Gallstones are present in 70-90% of cases. Indications for prophylactic cholecystectomy in ASYMPTOMATIC gallstones: gallbladder polyps ≥10mm (or ≥6mm with risk factors — age >50, sessile morphology, Indian ethnicity, primary sclerosing cholangitis); porcelain gallbladder (calcified wall — though the associated cancer risk has been revised downward from historical figures, selective/incomplete calcification still warrants cholecystectomy); stones >3cm; anomalous pancreaticobiliary junction; and in some settings, chronic typhoid carriage.
ERCP indications and post-ERCP pancreatitis prophylaxis
Endoscopy/ESGE
ERCP should be therapeutic, not diagnostic — MRCP and EUS have replaced diagnostic ERCP. Indications: choledocholithiasis (extraction); acute cholangitis (urgent decompression); gallstone pancreatitis with cholangitis or persistent obstruction; malignant biliary obstruction (stenting); bile leak. Post-ERCP pancreatitis (PEP): incidence 3-5%, higher in young women, difficult cannulation, sphincter of Oddi dysfunction, pancreatic duct injection. Prophylaxis (ESGE): rectal indomethacin or diclofenac 100mg immediately before or after ERCP for ALL patients without contraindication (reduces PEP by approximately 50%); aggressive periprocedural Lactated Ringer's hydration; prophylactic pancreatic duct stent in high-risk cases.

Latest GMJ coverage

Articles will appear here as the archive grows.

Frequently asked questions 12 Q&A — structured for Google featured snippets and AI discovery

Knowledge hub: guidelines, conventions and reports

Organizations working in migration and health

Related health topics

Gallstone pancreatitisBiliary and liver diseaseHepatobiliary malignancyObesity and rapid weight lossSurgical safety and bile duct injuryUpper GI symptom differential

About this hub. Produced by the GMJ News Editorial Team as a public-good service. Every statistic is linked to its primary source. Documents are preserved in the GMJ Repository with full attribution. Georgian Medical Journal · Contact the editorial team